Sign in

CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222343568
Phone
908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
  1. 424B5 Offering Prospectus
  2. 10-K/A Report 10-K/A
  3. 10-K Report Annual Report
  4. 424B5 Offering Prospectus
  5. 8-K Event Material agreement · Regulation FD disclosure
  6. 8-K Event Other events
  7. 8-K Event Regulation FD disclosure
  8. 4 Grant or award SVP and CFO acquired 16,000 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 47,000 shares (grant or award)
  10. 4 Grant or award See Remarks acquired 16,000 shares (grant or award)
  11. 4 Grant or award Director acquired 12,121 shares (grant or award)
  12. 4 Grant or award Director acquired 12,121 shares (grant or award)
  13. 4 Grant or award Director acquired 12,121 shares (grant or award)
  14. 4 Grant or award Director acquired 12,121 shares (grant or award)
  15. 4 Grant or award Director acquired 12,121 shares (grant or award)
  16. 4 Shares withheld for taxes SVP and CFO gave up 1,795 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Executive Officer gave up 4,478 shares (to pay taxes)
  18. 4 Shares withheld for taxes See Remarks gave up 1,795 shares (to pay taxes)
  19. 4 Grant or award Director acquired 8,747 shares (grant or award)
  20. 4 Grant or award Director acquired 8,747 shares (grant or award)

Page 17 of 80 · 1,585 filings